1. Home
  2. EIG vs IRWD Comparison

EIG vs IRWD Comparison

Compare EIG & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$41.95

Market Cap

754.0M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.58

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
IRWD
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
754.0M
663.6M
IPO Year
2006
2009

Fundamental Metrics

Financial Performance
Metric
EIG
IRWD
Price
$41.95
$3.58
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
163.0K
2.2M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
1400.00
EPS
0.52
0.24
Revenue
$858,700,000.00
$298,276,000.00
Revenue This Year
N/A
$57.95
Revenue Next Year
$1.26
$4.39
P/E Ratio
$79.98
$15.23
Revenue Growth
N/A
8.88
52 Week Low
$35.73
$0.55
52 Week High
$49.91
$5.78

Technical Indicators

Market Signals
Indicator
EIG
IRWD
Relative Strength Index (RSI) 52.20 39.56
Support Level $41.08 $3.07
Resistance Level $43.19 $3.92
Average True Range (ATR) 1.11 0.33
MACD -0.08 -0.11
Stochastic Oscillator 64.90 7.45

Price Performance

Historical Comparison
EIG
IRWD

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: